Cargando…

A comparative safety study of reported neurological adverse events with three COVID-19 vaccines

Detalles Bibliográficos
Autores principales:	Sodhi, Mohit, Samii, Ali, Etminan, Mahyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742704/ https://www.ncbi.nlm.nih.gov/pubmed/34999959 http://dx.doi.org/10.1007/s00415-021-10919-6

Ejemplares similares

Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines?
por: Etminan, Mahyar, et al.
Publicado: (2021)

Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?
por: Sodhi, Mohit, et al.
Publicado: (2020)

Neurological Adverse Events Associated with COVID-19 Vaccination
por: Jadali, Zohreh
Publicado: (2023)

Potential Biases in Studies of Acid-Suppressing Drugs and COVID-19 Infection
por: Etminan, Mahyar, et al.
Publicado: (2021)

Risk of Parkinson’s disease in patients with neovascular age-related macular degeneration
por: Etminan, Mahyar, et al.
Publicado: (2018)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
por: Shin, Hye-Rim, et al.
Publicado: (2022)

Association between the Levofloxacin Plasma Concentration and Neurological Adverse Events in an Elderly Patient
por: Kang, Gaeun, et al.
Publicado: (2019)

COVID-19 vaccine-related psychiatric adverse events: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

COVID-19 vaccine-related psychiatric adverse events: Mechanisms and considerations
por: Mopuru, Ranesh, et al.
Publicado: (2023)

Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

A practical guide to handling competing events in etiologic time-to-event studies
por: Mansournia, Mohammad Ali, et al.
Publicado: (2022)

Covid-19 vaccination, adverse events, and detection of antibodies
por: Kristensen, Søren Risom, et al.
Publicado: (2021)

Response to: Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination
por: Kim, Sohyeon, et al.
Publicado: (2023)

Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Pandemic Influenza A: H1N1 2009 Vaccine: A Concern on Neurological Adverse Effect
por: Wiwanitkit, Viroj
Publicado: (2012)

Response: Safety and adverse events following COVID‐19 vaccination among people with epilepsy: Correspondence
por: Ong, Marjorie Jia Yi, et al.
Publicado: (2022)

A review of the potential neurological adverse events of COVID-19 vaccines
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2022)

Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events
por: O´Sullivan, C., et al.
Publicado: (2021)

Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Vaccine trials with no serious adverse reactions – estimation of upper 95% confidence intervals for likelihood of such events
por: Grech, Victor, et al.
Publicado: (2022)

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
por: Chen, Yu-Wei, et al.
Publicado: (2021)

COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2022)

Adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Uncommon adverse events of intravesical Bacillus Calmette-Guérin treatment: A report of three cases
por: Topuz, Bahadır, et al.
Publicado: (2021)

Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination
por: Raw, Rachael Kathleen, et al.
Publicado: (2021)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023)

Severe hypoglycemia with trastuzumab: An unseen adverse event
por: Amrith, B. P., et al.
Publicado: (2019)

Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System
por: Nadeau Nguyen, Michelle C., et al.
Publicado: (2021)

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
por: Dutta, Siddhartha, et al.
Publicado: (2022)

Correspondence on adverse conditions of COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Reply: Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System
por: Cameron, Alan C., et al.
Publicado: (2021)

Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
por: Putzke, Joerg, et al.
Publicado: (2021)

Coping resources are transformed by the sequence of adverse life events
por: Brodziak, Andrzej, et al.
Publicado: (2013)

How to assess cryoballoon ablation‐related adverse events
por: Kataoka, Naoya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_poq90a5c0mk00s229h2ftnberb